T
Develops targeted radionuclide therapeutics, including a radiolabeled PSMA agent designed for low salivary gland uptake and astatine-211 agents for melanoma.
At a glance
- Founded: 2024
- HQ: Chapel Hill
- Sector: Biotech
See the full company record.
Founders, funding history and recent signals. Free accounts open immediately.
Listed roles
All Triangle rolesChecking listed roles…